HMGN Stock Price, Chart, Stats & News

Hemagen Diagnostics, Inc.
Save
Hemagen Diagnostics, Inc. (HMGN) does not currently pay a dividend.
3,100
Market cap
–
Current P/E
–
Forward P/E
HMGN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines.
Similar securities
Based on sector and market capitalization
Report issue





